Clinical Trial Update: Levosimendan for Cardiac Patients Undergoing Major Abdominal Cancer Surgeries [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating levosimendan in heart failure patients undergoing major abdominal cancer surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: National Cancer Institute, Egypt | Conditions: Heart Failure | Phase 2 | Status: COMPLETED